Notice Title

Consent to the Distribution of New Medicines

Publication Date
25 Jun 2026

Tags

Medicines Act Consent to the distribution of new medicines Health

Notice Number

2026-sl3473
Title
View PDF
File Type and Size
PDF (29 KB)

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:

Schedule

Product: Mounjaro (Pre-filled Pen)
Active Ingredient: Tirzepatide 5mg/mL
Dosage Form: Solution for injection
New Zealand Sponsor: Eli Lilly and Company (NZ) Limited
Manufacturers: Eli Lilly and Company Inc, Indiana, United States of America
Vetter Pharma-Fertigung GmbH & Co KG, Ravensburg, Germany
   
Product: Mounjaro (Vial)
Active Ingredient: Tirzepatide 5mg/mL
Dosage Form: Solution for injection
New Zealand Sponsor: Eli Lilly and Company (NZ) Limited
Manufacturer: BSP Pharmaceuticals SpA, Latina Scalo, Italy
   
Product: Mounjaro (KwikPen)
Active Ingredient: Tirzepatide 4.17mg/mL
Dosage Form: Solution for injection
New Zealand Sponsor: Eli Lilly and Company (NZ) Limited
Manufacturer: Eli Lilly Italia SpA, Florence, Italy
   
Product: Mounjaro (Pre-filled Pen)
Active Ingredient: Tirzepatide 10mg/mL
Dosage Form: Solution for injection
New Zealand Sponsor: Eli Lilly and Company (NZ) Limited
Manufacturers: Eli Lilly and Company Inc, Indiana, United States of America
Vetter Pharma-Fertigung GmbH & Co KG, Ravensburg, Germany
   
Product: Mounjaro (Vial)
Active Ingredient: Tirzepatide 10mg/mL
Dosage Form: Solution for injection
New Zealand Sponsor: Eli Lilly and Company (NZ) Limited
Manufacturer: BSP Pharmaceuticals SpA, Latina Scalo, Italy
   
Product: Mounjaro (Pre-filled Pen)
Active Ingredient: Tirzepatide 15mg/mL
Dosage Form: Solution for injection
New Zealand Sponsor: Eli Lilly and Company (NZ) Limited
Manufacturers: Eli Lilly and Company Inc, Indiana, United States of America
Vetter Pharma-Fertigung GmbH & Co KG, Ravensburg, Germany
   
Product: Mounjaro (Vial)
Active Ingredient: Tirzepatide 15mg/mL
Dosage Form: Solution for injection
New Zealand Sponsor: Eli Lilly and Company (NZ) Limited
Manufacturer: BSP Pharmaceuticals SpA, Latina Scalo, Italy
   
Product: Mounjaro (KwikPen)
Active Ingredient: Tirzepatide 8.33mg/mL
Dosage Form: Solution for injection
New Zealand Sponsor: Eli Lilly and Company (NZ) Limited
Manufacturer: Eli Lilly Italia SpA, Florence, Italy
   
Product: Mounjaro (Pre-filled Pen)
Active Ingredient: Tirzepatide 20mg/mL
Dosage Form: Solution for injection
New Zealand Sponsor: Eli Lilly and Company (NZ) Limited
Manufacturers: Eli Lilly and Company Inc, Indiana, United States of America
Vetter Pharma-Fertigung GmbH & Co KG, Ravensburg, Germany
   
Product: Mounjaro (Vial)
Active Ingredient: Tirzepatide 20mg/mL
Dosage Form: Solution for injection
New Zealand Sponsor: Eli Lilly and Company (NZ) Limited
Manufacturer: BSP Pharmaceuticals SpA, Latina Scalo, Italy
   
Product: Mounjaro (KwikPen)
Active Ingredient: Tirzepatide 12.5mg/mL
Dosage Form: Solution for injection
New Zealand Sponsor: Eli Lilly and Company (NZ) Limited
Manufacturer: Eli Lilly Italia SpA, Florence, Italy
   
Product: Mounjaro (Pre-filled Pen)
Active Ingredient: Tirzepatide 25mg/mL
Dosage Form: Solution for injection
New Zealand Sponsor: Eli Lilly and Company (NZ) Limited
Manufacturers: Eli Lilly and Company Inc, Indiana, United States of America
Vetter Pharma-Fertigung GmbH & Co KG, Ravensburg, Germany
   
Product: Mounjaro (Vial)
Active Ingredient: Tirzepatide 25mg/mL
Dosage Form: Solution for injection
New Zealand Sponsor: Eli Lilly and Company (NZ) Limited
Manufacturer: BSP Pharmaceuticals SpA, Latina Scalo, Italy
   
Product: Mounjaro (Pre-filled Pen)
Active Ingredient: Tirzepatide 30mg/mL
Dosage Form: Solution for injection
New Zealand Sponsor: Eli Lilly and Company (NZ) Limited
Manufacturers: Eli Lilly and Company Inc, Indiana, United States of America
Vetter Pharma-Fertigung GmbH & Co KG, Ravensburg, Germany
   
Product: Mounjaro (Vial)
Active Ingredient: Tirzepatide 30mg/mL
Dosage Form: Solution for injection
New Zealand Sponsor: Eli Lilly and Company (NZ) Limited
Manufacturer: BSP Pharmaceuticals SpA, Latina Scalo, Italy
   
Product: Mounjaro (KwikPen)
Active Ingredient: Tirzepatide 16.67mg/mL
Dosage Form: Solution for injection
New Zealand Sponsor: Eli Lilly and Company (NZ) Limited
Manufacturer: Eli Lilly Italia SpA, Florence, Italy
   
Product: Mounjaro (KwikPen)
Active Ingredient: Tirzepatide 20.83mg/mL
Dosage Form: Solution for injection
New Zealand Sponsor: Eli Lilly and Company (NZ) Limited
Manufacturer: Eli Lilly Italia SpA, Florence, Italy
   
Product: Mounjaro (KwikPen)
Active Ingredient: Tirzepatide 25mg/mL
Dosage Form: Solution for injection
New Zealand Sponsor: Eli Lilly and Company (NZ) Limited
Manufacturer: Eli Lilly Italia SpA, Florence, Italy
   
Product: Opdivo (40mg/4mL)
Active Ingredient: Nivolumab 10mg/mL
Dosage Form: Concentrate for infusion
New Zealand Sponsor: Bristol-Myers Squibb (NZ) Limited
Manufacturers: Vetter Pharma-Fertigung GmbH & Co KG, Ravensburg, Germany
Bristol-Myers Squibb Holdings Pharma Limited, Manati, Puerto Rico
   
Product: Opdivo (100mg/10mL)
Active Ingredient: Nivolumab 10mg/mL
Dosage Form: Concentrate for infusion
New Zealand Sponsor: Bristol-Myers Squibb (NZ) Limited
Manufacturers: Vetter Pharma-Fertigung GmbH & Co KG, Ravensburg, Germany
Bristol-Myers Squibb Holdings Pharma Limited, Manati, Puerto Rico


Dated this 22nd day of June 2026.

CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).